Higher power short duration vs. lower power longer duration posterior wall ablation for atrial fibrillation and oesophageal injury outcomes: a prospective multi-centre randomized controlled study (Hi-Lo HEAT trial)
EP Europace · 16.02.2023 · 25 (2) · 417-424
DOI: 10.1093/europace/euac190 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift EP Europace, online erschienen am 28.10.2022. Verfasst von David Chieng und 16 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Electrophysiology Research, Baker Heart and Diabetes Research Institute, 55 Commercial Road, Melbourne, Victoria 3004, Australia. Hauptthemen laut MEDLINE: Atrial Fibrillation, Pulmonary Veins, Radiofrequency Ablation, Catheter Ablation. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Aims
Radiofrequency (RF) ablation for pulmonary vein isolation (PVI) in atrial fibrillation (AF) is associated with the risk of oesophageal thermal injury (ETI). Higher power short duration (HPSD) ablation results in preferential local resistive heating over distal conductive heating. Although HPSD has become increasingly common, no randomized study has compared ETI risk with conventional lower power longer duration (LPLD) ablation. This study aims to compare HPSD vs. LPLD ablation on ETI risk. Methods and results Eighty-eight patients were randomized 1:1 to HPSD or LPLD posterior wall (PW) ablation. Posterior wall ablation was 40 W (HPSD group) or 25 W (LPLD group), with target AI (ablation index) 400/LSI (lesion size index) 4. Anterior wall ablation was 40–50 W, with a target AI 500–550/LSI 5–5.5. Endoscopy was performed on Day 1. The primary endpoint was ETI incidence. The mean age was 61 ± 9 years (31% females). The incidence of ETI (superficial ulcers n = 4) was 4.5%, with equal occurrence in HPSD and LPLD (P = 1.0). There was no difference in the median value of maximal oesophageal temperature (HPSD 38.6°C vs. LPLD 38.7°C, P = 0.43), or the median number of lesions per patient with temperature rise above 39°C (HPSD 1.5 vs. LPLD 2, P = 0.93). Radiofrequency ablation time (23.8 vs. 29.7 min, P < 0.01), PVI duration (46.5 vs. 59 min, P = 0.01), and procedure duration (133 vs. 150 min, P = 0.05) were reduced in HPSD. After a median follow-up of 12 months, AF recurrence was lower in HPSD (15.9% vs. LPLD 34.1%; hazard ratio 0.42, log-rank P = 0.04).
Conclusion
Higher power short duration ablation was associated with similarly low rates of ETI and shorter total/PVI RF ablation times when compared with LPLD ablation. Higher power short duration ablation is a safe and efficacious approach to PVI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Electrophysiology Research, Baker Heart and Diabetes Research Institute, 55 Commercial Road, Melbourne, Victoria 3004, Australia.
- Department of Cardiology, Alfred Hospital, 55 Commercial Road, Melbourne, Victoria 3004, Australia.
- School of Medicine, University of Melbourne, Parkville, Victoria 3010, Australia.
- Department of Cardiology, Cabrini Hospital, 181/183 Wattletree Road, Malvern, Victoria 3144, Australia.
- Department of Cardiology, Royal Melbourne Hospital, 300 Grattan Street, Parkville, Victoria 3050, Australia.
- Department of Gastroenterology, Alfred Hospital, 55 Commercial Road, Melbourne, Victoria 3004, Australia.
ORCID-Profile: David Chieng, Louise Segan, Hariharan Sugumar, Ahmed Al-Kaisey, Joshua Hawson, Michael C Y Nam, Sandeep Prabhu, Liang-Han Ling, Gregor Brown, Joseph Morton, Henry Debinski, Jonathan M Kalman, Peter M Kistler
Zitieren
APA
Chieng, D., Segan, L., Sugumar, H., Al-Kaisey, A., Hawson, J., Moore, B. M., Nam, M. C. Y., Voskoboinik, A., Prabhu, S., Ling, L. H., Ng, J. F., Brown, G., Lee, G., Morton, J., Debinski, H., Kalman, J. M., & Kistler, P. M. (2023). Higher power short duration vs. lower power longer duration posterior wall ablation for atrial fibrillation and oesophageal injury outcomes: a prospective multi-centre randomized controlled study (Hi-Lo HEAT trial). EP Europace, 25(2), 417-424. https://doi.org/10.1093/europace/euac190
Vancouver
Chieng D, Segan L, Sugumar H, Al-Kaisey A, Hawson J, Moore BM, et al. Higher power short duration vs. lower power longer duration posterior wall ablation for atrial fibrillation and oesophageal injury outcomes: a prospective multi-centre randomized controlled study (Hi-Lo HEAT trial). EP Europace. 2023;25(2):417-424. doi:10.1093/europace/euac190
BibTeX
@article{Chieng2023,
author = {Chieng, David and Segan, Louise and Sugumar, Hariharan and Al-Kaisey, Ahmed and Hawson, Joshua and Moore, Benjamin M and Nam, Michael C Y and Voskoboinik, Aleksandr and Prabhu, Sandeep and Ling, Liang-Han and Ng, Jer Fuu and Brown, Gregor and Lee, Geoffrey and Morton, Joseph and Debinski, Henry and Kalman, Jonathan M and Kistler, Peter M},
title = {Higher power short duration vs. lower power longer duration posterior wall ablation for atrial fibrillation and oesophageal injury outcomes: a prospective multi-centre randomized controlled study (Hi-Lo HEAT trial)},
journal = {EP Europace},
year = {2023},
volume = {25},
number = {2},
pages = {417--424},
doi = {10.1093/europace/euac190}
}
EUVIMED